专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2015024668A2 RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE 审中-公开
标题翻译：呼吸道合胞病毒（RSV）疫苗
公开(公告)号：WO2015024668A2
公开(公告)日：2015-02-26
申请号：PCT/EP2014002301
申请日：2014-08-21
申请人： CUREVAC GMBH
发明人： KRAMPS THOMAS , SCHNEE MARGIT , VOSS DANIEL , PETSCH BENJAMIN
IPC分类号： A61K39/155
CPC分类号： C07K14/005 , A61K39/12 , A61K39/155 , A61K48/00 , A61K2039/505 , A61K2039/53 , A61K2039/6031 , C07K16/1027 , C07K2317/24 , C12N7/00 , C12N2760/18534
摘要： The present invention relates to an mRNA sequence, comprising a coding region, encoding at least one antigenic peptide or protein of RSV infections Respiratory syncytial virus (RSV) or a fragment, variant or derivative thereof. Additionally the present invention relates to a composition comprising a plurality of mRNA sequences comprising a coding region, encoding at least one antigenic peptide or protein of RSV infections Respiratory syncytial virus (RSV) or a fragment, variant or derivative thereof. Furthermore it also discloses the use of the mRNA sequence or the composition comprising a plurality of mRNA sequences for the preparation of a pharmaceutical composition, especially a vaccine, e.g. for use in the prophylaxis or treatment of RSV infections Respiratory syncytial virus (RSV) infections. The present invention further describes a method of treatment or prophylaxis of RSV infections using the mRNA sequence.
摘要翻译：本发明涉及包含编码RSV感染的至少一种抗原性肽或蛋白质的编码区的mRNA序列。呼吸道合胞病毒（RSV）或其片段，变体或衍生物。另外，本发明涉及包含多个包含编码区的编码至少一种RSV感染的抗原性肽或蛋白质的mRNA序列的组合物。呼吸道合胞病毒（RSV）或其片段，变体或衍生物。此外，它还公开了mRNA序列或包含多个mRNA序列的组合物用于制备药物组合物，特别是疫苗例如人血清白蛋白的用途。用于预防或治疗RSV感染呼吸道合胞病毒（RSV）感染。本发明进一步描述了使用mRNA序列治疗或预防RSV感染的方法。

2. 发明申请

WO2009095226A2 NUCLEIC ACIDS OF FORMULA (I) (NUGLXMGNNV)A AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENT/ADJUVANT 审中-公开
标题翻译：制剂（I）（NUGLXMGNNV）的核酸及其作为免疫调节剂/调节剂的衍生物
公开(公告)号：WO2009095226A2
公开(公告)日：2009-08-06
申请号：PCT/EP2009000546
申请日：2009-01-28
申请人： CUREVAC GMBH , KRAMPS THOMAS , VOSS SOEHNKE , PROBST JOCHEN , HOERR INGMAR
发明人： KRAMPS THOMAS , VOSS SOEHNKE , PROBST JOCHEN , HOERR INGMAR
IPC分类号： C12N15/09 , A61K39/39 , C12N15/117
CPC分类号： A61K39/39 , A61K2039/53 , A61K2039/55561 , A61K2039/572 , C07H21/00 , C12N15/117 , C12N2310/17 , C12N2310/314 , C12N2310/315 , C12N2320/31
摘要： The present invention relates to nucleic acids of the general formula (I): (NuGlXmGnNv)a and derivatives thereof as an immunostimulating agent/adjuvant and to compositions containing same, optionally comprising an additional adjuvant. The present invention furthermore relates to a pharmaceutical composition or to a vaccine, each containing nucleic acids of formula (I) above and/or derivatives thereof as an immunostimulating agent, and optionally at least one additional pharmaceutically active component, e.g. an antigenic agent. The present invention relates likewise to the use of the pharmaceutical composition or of the vaccine for the treatment of cancer diseases, infectious diseases, allergies and autoimmune diseases etc. Likewise, the present invention includes the use of nucleic acids of the general formula (I): (NuGlXmGnNv)a and/or derivatives thereof for the preparation of a pharmaceutical composition for the treatment of such diseases.
摘要翻译：本发明涉及通式（I）的核酸：（NuG1XmGnNv）a及其衍生物作为免疫刺激剂/佐剂和含有其的组合物，任选地包含另外的佐剂。本发明还涉及药物组合物或疫苗，其各自含有上述式（I）核酸和/或其衍生物作为免疫刺激剂，以及任选的至少一种另外的药物活性成分，例如，抗原剂。本发明同样涉及药物组合物或疫苗用于治疗癌症疾病，感染性疾病，过敏症和自身免疫疾病等的用途。同样地，本发明包括通式（I）的核酸，：（NuGlXmGnNv）a和/或其衍生物，用于制备用于治疗这些疾病的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式